From July 26, 2022 to September 30, 2022, the company has repurchased 6,559,178 shares, representing 1.67% for $557.73 million. With this, the company has completed the repurchase of 6,559,178 shares, representing 1.67% for $557.73 million under the buyback announced on July 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.6 USD | -3.78% | -4.78% | +1.22% |
30/04 | Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology | CI |
26/04 | Wall Street: the worst week of 2024 is followed by the best | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.22% | 4.99TCr | |
-5.31% | 18TCr | |
-1.21% | 11TCr | |
-5.53% | 6.66TCr | |
+7.03% | 4.38TCr | |
+5.48% | 4.17TCr | |
+21.96% | 3.16TCr | |
+14.26% | 2.53TCr | |
-4.81% | 2.38TCr | |
-6.68% | 2.39TCr |
- Stock Market
- Equities
- DXCM Stock
- News DexCom, Inc.
- Tranche Update on DexCom, Inc.'s Equity Buyback Plan announced on July 28, 2022.